vs

Side-by-side financial comparison of HARROW, INC. (HROW) and Mama's Creations, Inc. (MAMA). Click either name above to swap in a different company.

HARROW, INC. is the larger business by last-quarter revenue ($89.1M vs $47.3M, roughly 1.9× Mama's Creations, Inc.). HARROW, INC. runs the higher net margin — 7.4% vs 1.1%, a 6.3% gap on every dollar of revenue. On growth, Mama's Creations, Inc. posted the faster year-over-year revenue change (50.0% vs 33.3%). HARROW, INC. produced more free cash flow last quarter ($8.1M vs $3.7M). Over the past eight quarters, HARROW, INC.'s revenue compounded faster (60.5% CAGR vs 33.0%).

Harrow Health, Inc., formerly known as Imprimis Pharmaceuticals, is a publicly traded pharmaceutical company based in Nashville, Tennessee.

Mama's Creations, Inc. is a U.S.-based food manufacturing enterprise that produces a wide portfolio of refrigerated ready-to-eat and heat-and-serve food products, including Italian-style meatballs, sausages, pasta dishes, and other prepared meals. It mainly distributes its offerings to grocery retailers, mass merchandisers and foodservice partners across the United States, focusing on convenient, high-quality comfort food for daily consumer demand.

HROW vs MAMA — Head-to-Head

Bigger by revenue
HROW
HROW
1.9× larger
HROW
$89.1M
$47.3M
MAMA
Growing faster (revenue YoY)
MAMA
MAMA
+16.6% gap
MAMA
50.0%
33.3%
HROW
Higher net margin
HROW
HROW
6.3% more per $
HROW
7.4%
1.1%
MAMA
More free cash flow
HROW
HROW
$4.4M more FCF
HROW
$8.1M
$3.7M
MAMA
Faster 2-yr revenue CAGR
HROW
HROW
Annualised
HROW
60.5%
33.0%
MAMA

Income Statement — Q4 FY2025 vs Q3 FY2026

Metric
HROW
HROW
MAMA
MAMA
Revenue
$89.1M
$47.3M
Net Profit
$6.6M
$540.0K
Gross Margin
79.3%
23.6%
Operating Margin
17.5%
1.7%
Net Margin
7.4%
1.1%
Revenue YoY
33.3%
50.0%
Net Profit YoY
-2.2%
31.7%
EPS (diluted)
$0.20
$0.01

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
HROW
HROW
MAMA
MAMA
Q4 25
$89.1M
$47.3M
Q3 25
$71.6M
$35.2M
Q2 25
$63.7M
$35.3M
Q1 25
$47.8M
$33.6M
Q4 24
$66.8M
$31.5M
Q3 24
$49.3M
$28.4M
Q2 24
$48.9M
$29.8M
Q1 24
$34.6M
$26.7M
Net Profit
HROW
HROW
MAMA
MAMA
Q4 25
$6.6M
$540.0K
Q3 25
$1.0M
$1.3M
Q2 25
$5.0M
$1.2M
Q1 25
$-17.8M
$1.6M
Q4 24
$6.8M
$410.0K
Q3 24
$-4.2M
$1.1M
Q2 24
$-6.5M
$553.0K
Q1 24
$-13.6M
$1.4M
Gross Margin
HROW
HROW
MAMA
MAMA
Q4 25
79.3%
23.6%
Q3 25
75.3%
24.9%
Q2 25
74.5%
26.1%
Q1 25
67.5%
27.0%
Q4 24
78.8%
22.6%
Q3 24
75.6%
24.2%
Q2 24
74.4%
25.0%
Q1 24
69.5%
29.3%
Operating Margin
HROW
HROW
MAMA
MAMA
Q4 25
17.5%
1.7%
Q3 25
20.6%
4.8%
Q2 25
17.9%
4.5%
Q1 25
-23.5%
5.7%
Q4 24
19.3%
1.8%
Q3 24
2.7%
5.7%
Q2 24
3.1%
2.6%
Q1 24
-20.0%
7.4%
Net Margin
HROW
HROW
MAMA
MAMA
Q4 25
7.4%
1.1%
Q3 25
1.4%
3.6%
Q2 25
7.8%
3.5%
Q1 25
-37.2%
4.8%
Q4 24
10.1%
1.3%
Q3 24
-8.6%
4.0%
Q2 24
-13.2%
1.9%
Q1 24
-39.2%
5.3%
EPS (diluted)
HROW
HROW
MAMA
MAMA
Q4 25
$0.20
$0.01
Q3 25
$0.03
$0.03
Q2 25
$0.13
$0.03
Q1 25
$-0.50
$0.04
Q4 24
$0.19
$0.01
Q3 24
$-0.12
$0.03
Q2 24
$-0.18
$0.01
Q1 24
$-0.38
$0.03

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
HROW
HROW
MAMA
MAMA
Cash + ST InvestmentsLiquidity on hand
$72.9M
$18.1M
Total DebtLower is stronger
$250.0M
Stockholders' EquityBook value
$52.4M
$49.6M
Total Assets
$399.5M
$84.0M
Debt / EquityLower = less leverage
4.77×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
HROW
HROW
MAMA
MAMA
Q4 25
$72.9M
$18.1M
Q3 25
$74.3M
$9.4M
Q2 25
$53.0M
$12.0M
Q1 25
$66.7M
$7.2M
Q4 24
$47.2M
$9.3M
Q3 24
$72.6M
$7.4M
Q2 24
$71.0M
$13.0M
Q1 24
$76.0M
$11.0M
Total Debt
HROW
HROW
MAMA
MAMA
Q4 25
$250.0M
Q3 25
$347.2M
Q2 25
$250.6M
Q1 25
$256.9M
Q4 24
$262.7M
Q3 24
$230.7M
Q2 24
$236.3M
Q1 24
$243.4M
Stockholders' Equity
HROW
HROW
MAMA
MAMA
Q4 25
$52.4M
$49.6M
Q3 25
$47.0M
$29.6M
Q2 25
$49.7M
$26.4M
Q1 25
$56.5M
$24.9M
Q4 24
$69.7M
$23.0M
Q3 24
$58.0M
$22.3M
Q2 24
$58.5M
$20.3M
Q1 24
$60.6M
$19.6M
Total Assets
HROW
HROW
MAMA
MAMA
Q4 25
$399.5M
$84.0M
Q3 25
$363.1M
$51.2M
Q2 25
$345.0M
$52.7M
Q1 25
$364.2M
$47.1M
Q4 24
$389.0M
$47.9M
Q3 24
$351.5M
$43.0M
Q2 24
$306.6M
$47.2M
Q1 24
$295.5M
$45.1M
Debt / Equity
HROW
HROW
MAMA
MAMA
Q4 25
4.77×
Q3 25
7.39×
Q2 25
5.05×
Q1 25
4.55×
Q4 24
3.77×
Q3 24
3.98×
Q2 24
4.04×
Q1 24
4.02×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
HROW
HROW
MAMA
MAMA
Operating Cash FlowLast quarter
$8.4M
$3.9M
Free Cash FlowOCF − Capex
$8.1M
$3.7M
FCF MarginFCF / Revenue
9.1%
7.8%
Capex IntensityCapex / Revenue
0.4%
0.4%
Cash ConversionOCF / Net Profit
1.27×
7.16×
TTM Free Cash FlowTrailing 4 quarters
$43.0M
$6.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
HROW
HROW
MAMA
MAMA
Q4 25
$8.4M
$3.9M
Q3 25
$16.6M
$-1.7M
Q2 25
$-803.0K
$6.0M
Q1 25
$19.7M
$-857.0K
Q4 24
$-17.8M
$4.8M
Q3 24
$3.0M
$-2.4M
Q2 24
$-2.7M
$3.6M
Q1 24
$-4.6M
$6.7M
Free Cash Flow
HROW
HROW
MAMA
MAMA
Q4 25
$8.1M
$3.7M
Q3 25
$16.4M
$-2.2M
Q2 25
$-969.0K
$5.5M
Q1 25
$19.5M
$-930.0K
Q4 24
$-18.3M
$2.5M
Q3 24
$2.3M
$-4.0M
Q2 24
$-3.1M
$2.5M
Q1 24
$-4.7M
$6.6M
FCF Margin
HROW
HROW
MAMA
MAMA
Q4 25
9.1%
7.8%
Q3 25
22.9%
-6.2%
Q2 25
-1.5%
15.5%
Q1 25
40.8%
-2.8%
Q4 24
-27.4%
8.0%
Q3 24
4.8%
-14.1%
Q2 24
-6.3%
8.4%
Q1 24
-13.6%
24.8%
Capex Intensity
HROW
HROW
MAMA
MAMA
Q4 25
0.4%
0.4%
Q3 25
0.3%
1.5%
Q2 25
0.3%
1.5%
Q1 25
0.4%
0.2%
Q4 24
0.8%
7.2%
Q3 24
1.2%
5.6%
Q2 24
0.7%
3.8%
Q1 24
0.3%
0.4%
Cash Conversion
HROW
HROW
MAMA
MAMA
Q4 25
1.27×
7.16×
Q3 25
16.26×
-1.31×
Q2 25
-0.16×
4.85×
Q1 25
-0.54×
Q4 24
-2.62×
11.71×
Q3 24
-2.10×
Q2 24
6.58×
Q1 24
4.79×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons